Cargando…
P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML-CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429670/ http://dx.doi.org/10.1097/01.HS9.0000969640.53011.8d |
| _version_ | 1785090771100106752 |
|---|---|
| author | Huang, Jian Zhang, Xinlu Feng, Weiying Qian, Honglan Yu, Chen Liu, Lirong Chen, Dan Zhu, Xiaoqiong Wang, Huafeng Yang, Xiudi Zhu, Jingjing Wu, Dijiong Zhou, Mei Lu, Ying Wang, Yi Tong, Hongyan Jin, Jie |
| author_facet | Huang, Jian Zhang, Xinlu Feng, Weiying Qian, Honglan Yu, Chen Liu, Lirong Chen, Dan Zhu, Xiaoqiong Wang, Huafeng Yang, Xiudi Zhu, Jingjing Wu, Dijiong Zhou, Mei Lu, Ying Wang, Yi Tong, Hongyan Jin, Jie |
| author_sort | Huang, Jian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429670 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104296702023-08-17 P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML-CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS Huang, Jian Zhang, Xinlu Feng, Weiying Qian, Honglan Yu, Chen Liu, Lirong Chen, Dan Zhu, Xiaoqiong Wang, Huafeng Yang, Xiudi Zhu, Jingjing Wu, Dijiong Zhou, Mei Lu, Ying Wang, Yi Tong, Hongyan Jin, Jie Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429670/ http://dx.doi.org/10.1097/01.HS9.0000969640.53011.8d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Huang, Jian Zhang, Xinlu Feng, Weiying Qian, Honglan Yu, Chen Liu, Lirong Chen, Dan Zhu, Xiaoqiong Wang, Huafeng Yang, Xiudi Zhu, Jingjing Wu, Dijiong Zhou, Mei Lu, Ying Wang, Yi Tong, Hongyan Jin, Jie P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML-CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS |
| title | P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML-CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS |
| title_full | P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML-CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS |
| title_fullStr | P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML-CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS |
| title_full_unstemmed | P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML-CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS |
| title_short | P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML-CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS |
| title_sort | p684: a multicenter retrospective study in china: clinical characteristics and prognosis of patients with cml-cp treated with different tyrosine kinase inhibitors |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429670/ http://dx.doi.org/10.1097/01.HS9.0000969640.53011.8d |
| work_keys_str_mv | AT huangjian p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT zhangxinlu p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT fengweiying p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT qianhonglan p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT yuchen p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT liulirong p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT chendan p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT zhuxiaoqiong p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT wanghuafeng p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT yangxiudi p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT zhujingjing p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT wudijiong p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT zhoumei p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT luying p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT wangyi p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT tonghongyan p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors AT jinjie p684amulticenterretrospectivestudyinchinaclinicalcharacteristicsandprognosisofpatientswithcmlcptreatedwithdifferenttyrosinekinaseinhibitors |